High false negative rate with PFTs in scleroderma lung disease
(HealthDay)—Use of pulmonary function tests (PFTs) is associated with high false negative rates for detection of scleroderma-associated interstitial lung disease (SSc-ILD), according to a study publis
Updated on: March 24,2024
19
High false negative rate with PFTs in scleroderma lung disease
(HealthDay)—Use of pulmonary function tests (PFTs) is associated with high false negative rates for detection of scleroderma-associated interstitial lung disease (SSc-ILD), according to a study publis
Updated on:March 24,2024
19